| Factor Information | |
|---|---|
| Data ID | 78 |
| Factor | SGA birth |
| Description | 12.8% (95% CI, 11.5%-14.3%) of women with ACHD delivered an SGA infant compared with 8.7% (95% CI, 8.7%-8.8%) of women without ACHD. |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | SGA Births |
| p Value | <0.05 |
| OR | 1.4 |
| Conclusion | Certain ACHD subtypes may be associated with increased odds of adverse maternal and should be monitored closely during pregnancy, and prenatal counseling provided to address these risks and any mitigation strategies. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 0 |
| CHD Type | |
| CHD Subtype | |
| Reference | |
|---|---|
| PMID | 31074818 |
| Year | 2019 |
| Title | Association of Adult Congenital Heart Disease With Pregnancy, Maternal, and Neonatal Outcomes. |
| Sample | ||
|---|---|---|
| Population | Adults (women) | |
| Source | Discharge Abstract Database | |
| Region | all hospitalizations in Canada (except Quebec), Canada | |
| Method | cross-sectional study | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | infants of women with any type of ACHD(Treatment) | infants of women without ACHD(Control) |
| Number | 269 (total:2114) | 230895 (total:2682451) |
| Age | 29.4±5.7 (M±SD) | 29.8±5.6 (M±SD) |
| Gender (Male: Female) | 0:269 | 0:230895 |
| Marker Level | 0.128 | 0.087 |
